Related Experiment Video
Updated: Mar 19, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
HMPV Virus Outbreak: First Review in Literature
Sonia Dubey1, Purushottam Lal2, Nitin Kumar3
1Department of Orthodontics and Dentofacial Orthopaedics, Kalinga Institute of Dental Sciences, KIIT Deemed to be University, Patia, Bhubaneswar, India.
Abstract:
Human metapneumovirus (HMPV), a pathogen within the Pneumoviridae family, is a notable contributor to respiratory tract infections worldwide. Identified in 2001, HMPV predominantly affects young children, the elderly, and individuals with compromised immune systems. The virus exhibits seasonal patterns, with infection rates typically increasing during late winter and spring. The virus spreads through respiratory droplets, leading to symptoms ranging from mild upper respiratory tract infections to severe lower respiratory illnesses such as bronchiolitis and pneumonia. Recent surges in HMPV cases, notably the 2024-2025 outbreak in China, have underscored the importance of understanding its epidemiology, transmission mechanisms, and clinical impact. Despite its clinical significance, there are currently no specific antiviral treatments or vaccines available for HMPV, making prevention strategies and supportive care essential components of management. This review provides a comprehensive overview of HMPV, including its virology, epidemiology, clinical manifestations, diagnostic methods, treatment options, and preventive measures, with a focus on recent outbreaks and their implications for public health.
Insights
Human metapneumovirus (HMPV) causes respiratory infections globally, particularly in vulnerable groups. Understanding its spread and symptoms is crucial, especially with recent outbreaks, as no specific treatments exist.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Human metapneumovirus (HMPV) is a significant cause of respiratory tract infections worldwide.
- First identified in 2001, HMPV disproportionately affects young children, the elderly, and immunocompromised individuals.
- The virus follows seasonal patterns, peaking in late winter and spring, and spreads via respiratory droplets.
Purpose of the Study:
- To provide a comprehensive review of HMPV.
- To detail its virology, epidemiology, clinical features, diagnostics, and management.
- To highlight recent outbreaks and their public health implications.
Main Methods:
- Literature review of HMPV virology and epidemiology.
- Analysis of clinical manifestations and diagnostic approaches.
- Examination of current treatment and prevention strategies.
Main Results:
- HMPV causes a spectrum of respiratory illnesses, from mild to severe (bronchiolitis, pneumonia).
- Recent outbreaks, such as the 2024-2025 event in China, emphasize the need for vigilance.
- No specific antiviral therapies or vaccines are currently available for HMPV.
Conclusions:
- Effective management relies on supportive care and preventive measures.
- Further research into HMPV is essential for developing targeted interventions.
- Understanding HMPV epidemiology is critical for public health preparedness.
Related Concept Videos
Retroviruses
Cytomegalovirus Disease

